drugset / Trial / NCT02574572

Autologous Mesenchymal Stem Cells Transplantation in Cervical Chronic and Complete Spinal Cord Injury

NCT02574572

Phase 1 Unknown 10 enrolled Hospital Sao Rafael
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to analyze the safety and efficacy of autologous bone marrow mesenchymal stem cell transplantation in patients with cervical chronic and complete spinal cord injury.

Timeline

Start
2017-09-06
Primary completion
2019-12-31
Completion
2020-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy Other

Indications